Planning your next step? Explore our cost guides, decision FAQs and treatment and country comparisons.
On this page
- Why a headline price is close to meaningless
- The variables that move the number
- What is usually not in the headline figure
- Why a very low price is a warning rather than a bargain
- Why Thailand costs less than the United States
- Comparing quotes properly
- What insurance does
- The comparison nobody quotes
- What we will tell you
- Frequently asked questions
- Requesting a medical evaluation
Nobody can give you a single figure, and a clinic that does is telling you something about how it prices rather than about what you need. Stem cell treatment cost in Thailand depends on the cell type, the dose, the number of treatments and what has to happen before any of it — and understanding those variables is what lets you compare two quotes at all.
Why a headline price is close to meaningless
“Stem cell therapy” is a category, not a product. A single intra-articular injection of donor cells into one knee and a course of autologous infusions prepared over six weeks are both described that way, and they are not comparable purchases.
Published trial doses vary by more than an order of magnitude, which means two treatments at the same price may deliver very different numbers of cells — and two at different prices may deliver the same.
So the useful question is not “how much” but “how much of what”. Without the second half, price carries almost no information.
See MSC dosage research for how widely the numbers actually range.
The variables that move the number
Each of these changes cost independently, which is why quotes diverge so widely.
- Cell source — autologous requires a harvest procedure; donor cells do not.
- Dose — expressed per joint or per kilogram, and the single largest driver.
- Number of treatments — a randomised trial found repeated dosing beat a single dose, so courses are common.
- Expansion — culture over weeks costs laboratory time and carries its own quality control.
- Route — a joint injection, an infusion and an intrathecal administration are different procedures.
- Work needed first — imaging, blood tests, specialist review.
- Setting — anything requiring a hospital rather than a clinic costs more.
A quote that does not specify the first three is not a quote you can evaluate.
What is usually not in the headline figure
Pre-treatment imaging and laboratory work, if not already done. Specialist consultation. Follow-up visits and any repeat imaging.
The harvest procedure itself, where autologous cells are used, is sometimes priced separately from the injection.
Accommodation and the length of stay, which for autologous treatment can be weeks rather than days — see international patients.
And the cost of the assessment that concludes you are not suitable, which is a real possibility and worth asking about in advance.
Why a very low price is a warning rather than a bargain
Cells are expensive to produce properly. Culture facilities, characterisation, sterility and endotoxin testing and viability assays all cost money, and they are the parts a patient cannot see.
A price well below the market usually means fewer cells, no expansion, minimal testing, or a preparation that is not what it is described as.
The documented harms in this sector cluster around exactly those savings — see adverse events.
That is not an argument that expensive means good. It is an argument that cheap means something, and the something is usually in the preparation.
Why Thailand costs less than the United States
Partly ordinary medical-cost differences — staff, facilities and overheads are cheaper here, as they are for every procedure.
Mostly regulation. In the United States most expanded cell preparations are regulated as drugs requiring approval, so the comparison is often not between two prices but between a price and unavailability.
That gap is a difference in required evidence, not a discount on the same product — see the United States comparison and regulation in Thailand.
Comparing quotes properly
Put them side by side on the same variables rather than on the total.
- Cell type and source, autologous or allogeneic
- Cell count per treatment, and how that number was chosen
- Number of treatments included
- Whether expansion is included or the preparation is same-day
- What release testing the batch undergoes
- What follow-up is included, and for how long
- What is refundable if you are assessed as unsuitable
Two quotes that differ threefold often turn out to be for genuinely different treatments once this table is filled in. Occasionally the cheaper one is better value; more often the gap is explained by dose or by testing, and then it is not a discount at all.
What insurance does
Generally nothing. Most insurers class these treatments as experimental or investigational and exclude them, and travel policies rarely cover elective treatment sought abroad.
That also means complications may not be covered, which is a larger exposure than the treatment cost itself if something requires hospital care.
Check your policy wording before travelling rather than afterwards, and check specifically what it says about treatment you sought deliberately overseas.
There is a narrower question worth asking too: whether your existing travel or health cover would pay for repatriation if something went wrong. Several policies exclude events arising from elective treatment abroad entirely, which turns a clinical complication into a financial one.
The comparison nobody quotes
Against the alternatives, this is expensive. Structured exercise therapy for knee osteoarthritis has evidence at least as good and costs a fraction as much.
A corticosteroid injection costs very little. Physiotherapy costs little. Weight reduction costs nothing.
None of that means cell therapy is worthless. It means the honest framing is a paid option alongside cheaper ones with comparable evidence, not a last resort after everything failed — see osteoarthritis.
What we will tell you
The variables above, applied to your situation, after your records have been reviewed. Not a figure before anyone has seen your imaging.
If a review concludes there is no reasonable case for treatment, you will be told that — see the patient journey.
Message us on WhatsApp to ask about a records review.
Frequently asked questions
How much does it cost?
It depends on cell type, dose, number of treatments and what work is needed first. A single figure across that range would be misleading rather than helpful.
Why do quotes vary so much?
Because they are often for different treatments. Dose alone varies by more than tenfold in the published literature.
Is a cheap treatment a bargain?
Usually it means fewer cells, no expansion or minimal testing. Cells are expensive to produce properly, and the savings come from parts you cannot see.
Why is Thailand cheaper than the US?
Lower medical costs, and mostly regulation — most expanded preparations need drug approval there, so the real comparison is often price against unavailability.
Will my insurance pay?
Almost certainly not. Most insurers exclude these treatments as experimental, and complications may also fall outside cover.
What if I am assessed as unsuitable?
Ask what is refundable before paying anything. It is one of the more revealing questions you can put to a clinic.
Requesting a medical evaluation
Nothing on this page establishes whether any treatment is appropriate for you. That needs your history, your imaging and your current medications read by a clinician. If you would like that review, send your records and we will tell you honestly whether there is anything worth discussing — including when the answer is no.
This page is general information, not medical advice, and does not create a doctor–patient relationship. Regenerative treatments discussed here are in most cases investigational. Discuss any treatment with a clinician who knows your history.